BIO

Tell Me, Please

A US senator has sent letters to two biotech and pharmaceutical industry groups to ask about their approaches to handling sexual harassment, according to Stat News.

The Party at Bio Not Associated with Bio included nude or partially nude female dancers, prompting an outcry, BioCentury reports.

Industry reactions to the US Supreme Court's decision to invalidate patents on isolated gene sequences were immediate and ranged from elation to disappointment.

A Supreme Court decision against drug developers in Sorrell v. IMS Health could potentially hamper how pharmacy benefit managers can use physician prescription data to drive adoption of pharmacogenomically guided products.

The Senate may be close to passing the SBIR/STTR reauthorization act, which would boost agency set-asides for SBIR, increase the size of Phase I and Phase II awards, and allow VC-owned firms to apply.

A bi-partisan bill with a broad base of support aims to streamline the system.

In a filing with the federal appeals court, the DoJ attempted to strike a balance between rewarding inventions that result from genomic discoveries and ensuring that discoveries of natural phenomena remain in the "storehouse of knowledge of all men." Meanwhile, it's business as usual at the USPTO until the appeals court rules on Myriad's challenged BRCA patents.

The decision ultimately upholds the patent eligibility of certain innovations not tied to a physical instrument, such as software, data-driven processes, and medical diagnostics.

Pages

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.